Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) — Capital Reinvestment Ratio
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) has a Capital Reinvestment Ratio of 0.25x as of June 2023, meaning it reinvests 0% of its operating cash flow (€2.10 Billion) in capital expenditures (€524.46 Million). See Guangzhou Baiyunshan Pharmaceutical Hold (GU5) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Capital Reinvestment Ratio (2013–2024)
This chart tracks Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's Capital Reinvestment Ratio across 12 annual periods.
Annual Capital Reinvestment Ratio for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (2013–2024)
Year-by-year Capital Reinvestment Ratio for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited from 2013 to 2024. For live market cap and broader valuation context, see GU5 company net worth.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.33x | €3.44 Billion | €1.13 Billion | ▼ -17.4% |
| 2023 | 0.40x | €4.10 Billion | €1.63 Billion | ▲ +100.7% |
| 2022 | 0.20x | €7.00 Billion | €1.38 Billion | ▼ -10.6% |
| 2021 | 0.22x | €5.67 Billion | €1.25 Billion | ▼ -85.2% |
| 2020 | 1.50x | €585.19 Million | €876.50 Million | ▲ +213.5% |
| 2019 | 0.48x | €5.02 Billion | €2.40 Billion | ▲ +420.8% |
| 2018 | 0.09x | €5.22 Billion | €478.62 Million | ▼ -14.5% |
| 2017 | 0.11x | €1.83 Billion | €196.77 Million | ▲ +19.8% |
| 2016 | 0.09x | €2.54 Billion | €228.03 Million | ▼ -66.2% |
| 2015 | 0.27x | €1.94 Billion | €515.34 Million | ▲ +30.1% |
| 2014 | 0.20x | €1.75 Billion | €356.70 Million | ▼ -22.2% |
| 2013 | 0.26x | €1.34 Billion | €350.35 Million | — |